Your browser doesn't support javascript.
loading
Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm in Experimental Models of Hyperinflammation Syndrome.
Huarte, Eduardo; Peel, Michael T; Verbist, Katherine; Fay, Brittany L; Bassett, Rachel; Albeituni, Sabrin; Nichols, Kim E; Smith, Paul A.
Afiliação
  • Huarte E; Incyte Research Institute, Wilmington, DE, United States.
  • Peel MT; Incyte Research Institute, Wilmington, DE, United States.
  • Verbist K; St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Fay BL; Incyte Research Institute, Wilmington, DE, United States.
  • Bassett R; St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Albeituni S; St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Nichols KE; St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Smith PA; Incyte Research Institute, Wilmington, DE, United States.
Front Pharmacol ; 12: 650295, 2021.
Article em En | MEDLINE | ID: mdl-33981229
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article